stockrow
Saturday 7 November 2026
Export ADTX’s income statement to Excel — free account
Aditxt, Inc.
ADTX Healthcare Biotechnology
Aditxt, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3,200.00, down 97.6% from fiscal 2024.
- Revenue
- +1,120.0%
- EPS
- +99.6%
- Free cash flow
- +60.8%
Quarter to March 2026, against a year earlier
0.00
0.00
NaN
Follow ADTX
Alert me
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | 4 | 3 | 4 |
P/E ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | 0.00 | 19,164,606.36 | 0.00 | 0.00 | 303.30 |
Altman Z-Score |
— | — | — | — | 4,623,615.07 | 1,419,019.93 | (4.75) | (10.96) | (22.29) |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | (26.15) | (43.15) | (15.47) | (27.20) | (52.38) |
P/Operating CF |
— | — | — | — | (5,748,237.03) | (2,662,796.57) | 0.00 | 0.00 | (0.10) |
Beneish M-Score |
— | — | — | — | — | 2.23 | — | — | — |
P/B ratio |
— | — | — | — | 4,907,185.85 | 3,436,988.45 | 0.00 | 0.00 | 0.24 |
Price to Tangible BV |
— | — | — | — | 5,012,549.43 | 3,509,107.71 | 0.00 | 0.00 | 0.24 |
EV/Sales |
— | — | — | — | 0.00 | 19,164,604.81 | 1.89 | 3.61 | (303.83) |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
EV/Operating CF |
— | — | — | — | (2,242,519.39) | (799,124.31) | (0.06) | (0.03) | 0.04 |
EV/FCF |
— | — | — | — | (2,144,727.64) | (786,234.58) | (0.06) | (0.03) | 0.04 |
Quick Ratio |
0.42 | 0.07 | 0.00 | 8.56 | 2.21 | 0.90 | 0.23 | 0.08 | 0.26 |
Current Ratio |
0.42 | 0.07 | 0.00 | 8.99 | 2.61 | 1.30 | 0.27 | 0.09 | 0.31 |
Net Debt/EBITDA |
0.12 | (0.01) | 0.00 | 1.23 | 0.20 | 0.12 | 0.00 | 0.03 | 0.18 |
Debt/Assets |
0.00% | 141.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | (0.11) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.07 | 0.02 | 0.00 | 0.00 |
Operating CF/Net income |
0.00 | 0.07 | 0.08 | 0.79 | 0.48 | 0.81 | 0.59 | 0.42 | 0.60 |
Capex/Depreciation |
— | — | — | (0.54) | (0.44) | (0.18) | (0.01) | 0.00 | (0.01) |
Interest Coverage |
— | (140.59) | (3,089.89) | (878.44) | (449.95) | (33.84) | (6.21) | (6.65) | (28.73) |
| 26.68% | 712.66% | 265.57% | (224.26%) | (436.66%) | (359.88%) | (307.73%) | (470.92%) | (1,708.68%) | |
| (302.77%) | (9,834.40%) | (4,872.66%) | (138.41%) | (310.94%) | (202.11%) | (118.24%) | (105.19%) | (177.15%) | |
ROIC |
0.00% | 0.00% | 0.00% | (1,085.79%) | (1,135.24%) | (653.28%) | (102.13%) | (6,739.48%) | (1,619.88%) |
Return on Tangible Assets |
610.32% | 370.22% | 196.11% | (86.27%) | (572.86%) | (809.86%) | 191.47% | 203.19% | 573.29% |
Average Days of Receivables |
— | — | — | — | 312.16 | 206.40 | 3,311.14 | 3,138.46 | 0.00 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 4,802.48% | 778.42% | 1,096.45% | 8,123.96% | 99,815.63% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 21,351.81% | 1,910.14% | 2,925.67% | 12,301.57% | 511,778.13% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 4,419.71% | 335.38% | 217.30% | 5,034.10% | 15,103.13% |
Graham Net Nets |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | (9.30) |
Graham Number |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | 0.00% | 0.00% | (56.19%) | (61,114.84%) | (223,877.17%) |
Free Cash Flow Yield |
— | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% | (2,734.58%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 20.12 | 13,034,343.43 | 248,194.11 | 2.31 |
Operating CF per Share |
0.00 | (148.58) | (0.12) | (1.05) | (58.35) | (482.59) | (387,953,535.35) | (31,046,675.31) | (18,567.42) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.02) | (2.66) | (7.91) | (290,909.09) | 0.00 | (9.90) |
Free Cash Flow per Share |
0.00 | (148.58) | (0.12) | (1.07) | (61.01) | (490.50) | (388,244,444.44) | (31,046,675.31) | (18,577.32) |
Cash per Share |
0.24 | 44.50 | 0.00 | 1.52 | 20.62 | 59.67 | 1,961,616.16 | 1,542,878.31 | 2,311.93 |
Shareholders Equity per Share |
(0.58) | (591.04) | (0.74) | 1.60 | 26.67 | 112.20 | 324,177,777.78 | 2,021,485.46 | 2,857.71 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.58) | (591.04) | (0.74) | 1.60 | 26.67 | 112.20 | 324,177,777.78 | 2,021,485.46 | 2,857.71 |
Free Cash Flow |
— | (0.39) | (0.46) | (7.39) | (23.29) | (22.76) | (19.22) | (16.76) | (25.70) |
Working Capital |
(0.03) | (1.54) | (2.97) | 9.81 | 5.81 | 1.10 | (18.98) | (21.41) | (8.40) |
Capital Expenditures |
— | — | — | (0.17) | (1.02) | (0.37) | (0.01) | — | (0.01) |
Net Current Asset Value |
(0.06) | (1.54) | (2.97) | 8.95 | 2.93 | (0.79) | (21.62) | (29.05) | (8.74) |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
Capex to Sales |
— | — | — | 0.00 | 9.67 | 0.39 | 0.02 | 0.00 | 4.28 |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | — | — | 0.40 | 1.02 | 0.89 | 1.44 | 2.45 | 2.00 |
Cash ROIC |
0.00% | 30.72% | 16.31% | (34.36%) | (129.03%) | (285.38%) | (119.04%) | (871.03%) | (359.35%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 3.02 | 0.20 | 0.04 | 0.00 |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.02 | 0.09 | 0.43 | 0.14 | 0.06 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 1.06 | 0.89 | 1.66 | 0.34 |
Average Days of Payables |
— | 0.00 | 0.00 | 4,954.16 | 7,372.53 | 932.25 | 4,126.02 | 7,685.18 | 968,307.24 |
Days of Inventory on Hand |
— | — | — | 0.00 | 2,314.94 | 452.25 | 359.55 | 6.51 | 730.00 |
Average Receivables |
— | — | — | — | — | 0.31 | 3.19 | 3.50 | — |
Average Payables |
— | 1.45 | 1.45 | 1.04 | 0.91 | 1.77 | 5.26 | 10.88 | 10.45 |
Average Inventory |
— | — | — | — | — | 0.72 | 0.85 | 0.38 | 0.01 |
Average Assets |
0.07 | 0.06 | 0.12 | 6.61 | 14.88 | 13.70 | 27.66 | 38.36 | 24.33 |
Average Common Equity |
(0.80) | (0.80) | (2.19) | 4.08 | 10.60 | 7.69 | 10.63 | 8.57 | 2.52 |
Columns are period end dates · fundamentals updated 26 Oct 2026